ROSS GROUP PLC Logo

ROSS GROUP PLC

A holding company in liquidation, formerly providing supply chain management & technology solutions.

RGP | IL

Overview

Corporate Details

ISIN(s):
GB0002192606
LEI:
213800PIS2QRIKPZB546
Country:
United Kingdom
Address:
71-75 SHELTON STREET, WC2H 9JQ LONDON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ross Group PLC is a holding company currently in liquidation. Prior to entering liquidation, the company provided specialist, industry-agnostic supply chain management services for over a decade. Through its subsidiaries, Ross Group PLC was involved in engineering, manufacturing, and leading-edge technology solutions within the supply chain sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-08-13 09:33
Capital/Financing Update
Depositary change notice to investors
English 5.3 KB
2024-08-13 09:31
Delisting Announcement
RosAgro Listing cancellation notice
English 4.1 KB
2024-08-08 09:13
Legal Proceedings Report
Submission from the Ministry of Agriculture
English 5.1 KB
2024-08-05 11:40
Pre-Annual General Meeting Information
Notice of EGM
English 35.2 KB
2024-08-05 11:35
Interim Report
Half-year Report
English 484.5 KB
2024-07-15 12:02
Legal Proceedings Report
Inclusion in the list of ESO
English 4.8 KB
2024-06-27 14:00
Foreign Filer Report
Notice of change of the GDR program depositary
English 5.5 KB
2024-06-26 15:00
Delisting Announcement
Announcement of Intended Cancellation of Listing
English 4.8 KB
2024-06-26 13:46
Director's Dealing
BoD's member has bought the Company's GDRs
English 3.2 KB
2024-05-13 09:00
Earnings Release
1st Quarter Financial Results
English 355.0 KB
2024-04-08 10:00
Post-Annual General Meeting Information
AGM Statement
English 28.2 KB
2024-04-02 08:00
Pre-Annual General Meeting Information
Adjournment of Annual General Meeting (AGM)
English 6.4 KB
2024-03-19 08:00
Pre-Annual General Meeting Information
Notice of AGM
English 37.7 KB
2024-03-04 08:00
Annual / Quarterly Financial Statement
IFRS Consolidated FS and Auditors’ Report 2023
English 1.1 MB
2023-11-30 08:00
Post-Annual General Meeting Information
EGM Statement
English 23.3 KB

Automate Your Workflow. Get a real-time feed of all ROSS GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ROSS GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.